Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice
Authors
Keywords
PD-L1, STAT3, Cancer, Immunotherapy, Nanoparticle
Journal
LIFE SCIENCES
Volume 266, Issue -, Pages 118847
Publisher
Elsevier BV
Online
2020-12-10
DOI
10.1016/j.lfs.2020.118847
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Silencing of p68 and STAT3 synergistically diminishes cancer progression
- (2020) Vida Hashemi et al. LIFE SCIENCES
- Chitosan-modified hyaluronic acid-based nanosized drug carriers
- (2020) Árpád Turcsányi et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression
- (2020) Ali Masjedi et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Codelivery of STAT3 siRNA and BV6 by carboxymethyl dextran trimethyl chitosan nanoparticles suppresses cancer cell progression
- (2020) Afshin Nikkhoo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Coinhibition of S1PR1 and GP130 by siRNA‐loaded alginate‐conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells
- (2020) Narges Rostami et al. JOURNAL OF CELLULAR PHYSIOLOGY
- PD-L1/PD-1 axis as a potent therapeutic target in breast cancer
- (2020) Shima Bastaki et al. LIFE SCIENCES
- How microRNAs affect the PD-L1 and its synthetic pathway in cancer
- (2020) Gholamreza Rezaei Danbaran et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Concomitant blockade of A2AR and CTLA‐4 by siRNA‐loaded polyethylene glycol‐chitosan‐alginate nanoparticles synergistically enhances antitumor T‐cell responses
- (2020) Mitra Ghasemi‐Chaleshtari et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Inhibition of CD73 using folate targeted nanoparticles carrying anti-CD73 siRNA potentiates anticancer efficacy of Dinaciclib
- (2020) Shahin Hallaj et al. LIFE SCIENCES
- Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression
- (2020) Farnaz Hajizadeh et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine
- (2020) Maryam Esmaily et al. JOURNAL OF CONTROLLED RELEASE
- Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy
- (2020) Ali Masjedi et al. Nanomedicine-Nanotechnology Biology and Medicine
- Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression
- (2020) Sepideh Izadi et al. PHARMACEUTICAL RESEARCH
- CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment
- (2019) A. Tirella et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Tumor Dormancy and Interplay with Hypoxic Tumor Microenvironment
- (2019) Elena Butturini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- STAT3, a Master Regulator of Anti-Tumor Immune Response
- (2019) Rébé et al. Cancers
- Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccine
- (2019) Hadi Hassannia et al. IMMUNOLOGY
- Synthesis, Bioapplications, and Toxicity Evaluation of Chitosan-Based Nanoparticles
- (2019) Balsam R. Rizeq et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanisms Controlling PD-L1 Expression in Cancer
- (2019) Jong-Ho Cha et al. MOLECULAR CELL
- Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3
- (2018) Bingxin Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Anti‐inflammatory and anti‐tumor effects of α- l -guluronic acid (G2013) on cancer-related inflammation in a murine breast cancer model
- (2018) Fatemeh Hosseini et al. BIOMEDICINE & PHARMACOTHERAPY
- Inhibition of tumor growth by mouse ROR1 specific antibody in a syngeneic mouse tumor model
- (2018) Hadi Hassannia et al. IMMUNOLOGY LETTERS
- Anti-angiogenic effects of CD73-specific siRNA-loaded nanoparticles in breast cancer-bearing mice
- (2018) Ghasem Ghalamfarsa et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling
- (2018) Ying-Ya Cao et al. Cell Death & Disease
- Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
- (2018) Tammy Linlin Song et al. BLOOD
- The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cells
- (2018) Yue Zou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma
- (2018) Bin Huang et al. PATHOLOGY RESEARCH AND PRACTICE
- Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
- (2018) Peixin Dong et al. Frontiers in Oncology
- Nanoparticles and targeted drug delivery in cancer therapy
- (2017) Behdokht Bahrami et al. IMMUNOLOGY LETTERS
- PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer
- (2017) Xiaohui Zhang et al. International Journal of Clinical Oncology
- Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer
- (2017) Xin Luo et al. International Journal of Nanomedicine
- CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice
- (2017) Farhad Jadidi-Niaragh et al. JOURNAL OF CONTROLLED RELEASE
- Tat-Tagged and Folate-Modified N-Succinyl-chitosan (Tat-Suc-FA) Self-assembly Nanoparticle for Therapeutic Delivery OGX-011 to A549 Cells
- (2017) Chengyun Yan et al. MOLECULAR PHARMACEUTICS
- Increased efficacy of a dendritic cell–based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor
- (2017) Samaneh Arab et al. TUMOR BIOLOGY
- Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma
- (2017) Song Xue et al. Oncotarget
- miR-217 inhibits laryngeal cancer metastasis by repressing AEG-1 and PD-L1 expression
- (2017) Susheng Miao et al. Oncotarget
- Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies
- (2017) Neda Shajari et al. Current Drug Delivery
- Targeting of crosstalk between tumor and tumor microenvironment by β-D mannuronic acid (M2000) in murine breast cancer model
- (2017) Fatemeh Hosseini et al. Cancer Medicine
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Hyaluronic Acid Coated Chitosan Nanoparticles Reduced the Immunogenicity of the Formed Protein Corona
- (2017) Abdulaziz Almalik et al. Scientific Reports
- Immunotherapy and tumor microenvironment
- (2016) Haidong Tang et al. CANCER LETTERS
- Recent research progress on preparation and application of N, N, N-trimethyl chitosan
- (2016) Meiyan Wu et al. CARBOHYDRATE RESEARCH
- High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma
- (2016) Yih-Leong Chang et al. EUROPEAN JOURNAL OF CANCER
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles
- (2016) Farhad Jadidi-Niaragh et al. TUMOR BIOLOGY
- Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction
- (2016) Djoke Hendriks et al. OncoImmunology
- Preclinical and clinical development of siRNA-based therapeutics
- (2015) Gulnihal Ozcan et al. ADVANCED DRUG DELIVERY REVIEWS
- Stabilization of chitosan/hyaluronan colloidal polyelectrolyte complexes in physiological conditions
- (2015) Danjun Wu et al. CARBOHYDRATE POLYMERS
- Therapeutic applications of the cell-penetrating HIV-1 Tat peptide
- (2015) Mafalda Rizzuti et al. DRUG DISCOVERY TODAY
- Nanoparticulate immunotherapy for cancer
- (2015) Chintan H. Kapadia et al. JOURNAL OF CONTROLLED RELEASE
- Efficient Nontoxic Delivery of PD-L1 and PD-L2 siRNA Into Dendritic Cell Vaccines Using the Cationic Lipid SAINT-18
- (2015) Mieke W.H. Roeven et al. JOURNAL OF IMMUNOTHERAPY
- Ovarian Cancer Immunotherapy Using PD-L1 siRNA Targeted Delivery from Folic Acid-Functionalized Polyethylenimine: Strategies to Enhance T Cell Killing
- (2015) Pei Yun Teo et al. Advanced Healthcare Materials
- A Small Molecule Compound Targeting STAT3 DNA-Binding Domain Inhibits Cancer Cell Proliferation, Migration, and Invasion
- (2014) Wei Huang et al. ACS Chemical Biology
- Systemic Delivery of Small RNA Using Lipid Nanoparticles
- (2014) Tomohiro Asai et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- CD44-Targeted Docetaxel Conjugate for Cancer Cells and Cancer Stem-Like Cells: A Novel Hyaluronic Acid-Based Drug Delivery System
- (2014) Navid Goodarzi et al. Chemical Biology & Drug Design
- The chick embryo chorioallantoic membrane as a model for tumor biology
- (2014) Domenico Ribatti EXPERIMENTAL CELL RESEARCH
- Highly sensitive and selective anticancer effect by conjugated HA-cisplatin in non-small cell lung cancer overexpressed with CD44
- (2014) Yu Hua Quan et al. EXPERIMENTAL LUNG RESEARCH
- Blocking the bFGF/STAT3 interaction through specific signaling pathways induces apoptosis in glioblastoma cells
- (2014) Jingchao Wu et al. JOURNAL OF NEURO-ONCOLOGY
- STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo
- (2014) Aws Alshamsan et al. Translational Oncology
- Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway
- (2013) Mohammad Zahid Kamran et al. BIOMEDICINE & PHARMACOTHERAPY
- Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery
- (2013) Yangchao Luo et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Screening for Distress and Unmet Needs in Patients With Cancer: Review and Recommendations
- (2012) Linda E. Carlson et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia
- (2012) Farhad Jadidi-Niaragh et al. MEDICAL ONCOLOGY
- miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors
- (2011) Tal Melkman-Zehavi et al. EMBO JOURNAL
- Plasmid-based STAT3-siRNA efficiently inhibits breast tumor growth and metastasis in mice
- (2011) L. DAI et al. NEOPLASMA
- siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells
- (2010) W. Hobo et al. BLOOD
- Development of mucoadhesive thiolated chitosan nanoparticles for biomedical applications
- (2010) A. Anitha et al. CARBOHYDRATE POLYMERS
- PD-L1 expression on tolerogenic APCs is controlled by STAT-3
- (2010) Sabine J. Wölfle et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
- (2009) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started